Skip to main content
Caplight Logo









Pilot Gene Technology (Hangzhou) Co., Ltd.

Pilot Gene Technology (Hangzhou) Co., Ltd.

Private
HangzhouHealthcare & Life Scienceshttps://www.pilotgene.com/

Last Round

Series B

Sep 1, 2023

Total Funding Raised

$35.2M

Company Overview

Pilot Gene Technology (Hangzhou) Co., Ltd. is a biotechnology company that develops digital polymerase chain reaction (PCR) systems and molecular diagnostic solutions for clinical and research applications.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotech Equipment, Precision Medicine

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

droplet digital PCRdPCRmolecular diagnosticsnucleic acid extractionpathogen detectionprecision medicinediagnostic reagentslab automationbiotech equipmentclinical laboratoryabsolute quantificationPCR consumablesgenomics toolsliquid biopsy

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Pilot Gene Technology (Hangzhou) Co., Ltd. Comparables

Compare Pilot Gene Technology (Hangzhou) Co., Ltd. with similar companies based on industry and business-model similarity.

Pilot Gene Technology (Hangzhou) Co., Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Suzhou Sniper Medical Technologies Co., Ltd.
92%
TargetingOne Corporation
91%
Zhenzhun Bio-Tech
86%

Pilot Gene Technology (Hangzhou) Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BSep 1, 2023
Series A ExtensionJul 19, 2021
Series AJan 12, 2018

Pilot Gene Technology (Hangzhou) Co., Ltd. Investors

Notable investors and investment history

Pilot Gene Technology (Hangzhou) Co., Ltd. investors
InvestorRounds
Shenzhen Dachen Caizhi Venture Capital ManagementSeries A Extension
Share CapitalSeries B, Series A Extension

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 15, 2025

    Grew 300% QoQ from 1 to 4 employees.

  • Sep 1, 2023

    $14M round led by Share Capital.

Pilot Gene Technology (Hangzhou) Co., Ltd. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Pilot Gene Technology (Hangzhou) Co., Ltd. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Pilot Gene Technology (Hangzhou) Co., Ltd.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersHangzhou
Employee Range4
Year Founded2016
Last FundingSep 1, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?